MPM leads largest European VC financing of year
UK-based drug development company Oxagen has received almost £32m in a series B round of financing led by MPM Capital in its first European investment.
UK-based drug development company Oxagen has received almost £32m in a series B round of financing led by MPM Capital in its first European investment.
Copyright PEI Media
Not for publication, email or dissemination